Ophirex

Corte Madera, United States

Ophirex is developing affordable, accessible, oral treatments to snakebite.

$37.0M raised

Jan 2023

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ophirex raised?

Ophirex has raised $37.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.

Who are Ophirex's investors?

Ophirex's investors include AXA Investment Managers.

Where is Ophirex headquartered?

Ophirex is headquartered in Corte Madera, United States.

What does Ophirex do?

Ophirex is developing affordable, accessible, oral treatments to snakebite.

What stage is Ophirex at?

Ophirex is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 5, 2023.

MLA

"Ophirex — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/ophirex. Accessed July 5, 2026.

APA

VCBacked. (2023). Ophirex — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/ophirex

Wikipedia (cite web)

{{cite web |title=Ophirex — Funding & Investors |url=https://www.vcbacked.co/company/ophirex |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 5, 2023.